A public-health perspective on screening colonoscopy

Expert Review of Anticancer Therapy

Volumn 11, Issue 4, 2011, Pages 561-569

  Hoffman, Richard M ^a,b   Espey, David ^c,d   Rhyne, Robert L ^b  

^a NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c Albuquerque Area Indian Health Service   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

colonoscopy; colorectal neoplasms; complications; early detection of cancer; evidence based medicine; gastroenterology; healthcare; patient preference; quality indicators; utilization

Indexed keywords

BLEEDING; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HUMAN; OCCULT BLOOD TEST; PATIENT PREFERENCE; PERFORATION; POLYPECTOMY; PUBLIC HEALTH; REVIEW; SIGMOIDOSCOPY; VULNERABLE POPULATION;

COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79955105323     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.11.16     Document Type: Review

References (80)

1. US Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 149(9), 627-637 (2008).
2. Levin B, Lieberman DA, McFarland B et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134(5), 1570-1595 (2008). (Pubitemid 351615355)
3. Rex DK, Johnson DA, Anderson JC et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am. J. Gastroenterol. 104(3), 739-750 (2009).
4. CDC. Vital signs: colorectal cancer screening among adults aged 50-75 years - United States, 2008. MMWR Morb. Mortal. Wkly Rep. 59(10), 808-812 (2010).
5. ACOG Committee Opinion No. 384 November 2007: colonoscopy and colorectal cancer screening and prevention. Obstet. Gynecol. 110(5), 1199-1202 (2007).
6. Klabunde CN, Lanier D, Nadel MR et al. Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007. Am. J. Prev. Med. 37(1), 8-16 (2009).
7. Allen JD, Barlow WE, Duncan RP et al. NIH State-of-the-Science Conference Statement: enhancing use and quality of colorectal cancer screening. NIH Consens. State Sci. Statements 27(1), (2010).
8. Bretthauer M, Ekbom A, Malila N et al. [Politics and science in colorectal cancer screening]. Tidsskr. Nor. Laegeforen. 126(13), 1766-1767 (2006).
9. Winawer SJ, Zauber AG, O'Brien MJ et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N. Engl. J. Med. 328(13), 901-906 (1993). (Pubitemid 23086641)
10. Winawer SJ, Zauber AG, Ho MN et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N. Engl. J. Med. 329(27), 1977-1981 (1993). (Pubitemid 24015040)
11. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann. Intern. Med. 123(12), 904-910 (1995).
12. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch. Intern. Med. 155(16), 1741-1748 (1995).
13. Baxter NN, Goldwasser MA, Paszat LF et al. Association of colonoscopy and death from colorectal cancer. Ann. Intern. Med. 150(1), 1-8 (2009).
14. Karlitz JJ. The effectiveness of colonoscopy in reducing mortality from colorectal cancer. Ann. Intern. Med. 150(11), 816; author reply 819-820 (2009).
15. Weiss NS, Doria-Rose VP. The effectiveness of colonoscopy in reducing mortality from colorectal cancer. Ann. Intern. Med. 150(11), 817-818; author reply 819-820 (2009).
16. Ransohoff DF. How much does colonoscopy reduce colon cancer mortality? Ann. Intern. Med. 150(1), 50-52 (2009).
17. Brenner H, Hoffmeister M, Arndt V et al. Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J. Natl Cancer Inst. 102(2), 89-95 (2010).
18. Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann. Intern. Med. 154(1), 22-30 (2010).
19. Heresbach D, Barrioz T, Lapalus MG et al. Miss rate for colorectal neoplastic polyps: a prospective multicenter study of back-to-back video colonoscopies. Endoscopy 40(4), 284-290 (2008). (Pubitemid 351524375)
20. Soetikno RM, Kaltenbach T, Rouse RV et al. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA 299(9), 1027-1035 (2008). (Pubitemid 351347059)
21. Sugai T, Habano W, Jiao YF et al. Analysis of molecular alterations in left- and right-sided colorectal carcinomas reveals distinct pathways of carcinogenesis: proposal for new molecular profile of colorectal carcinomas. J. Mol. Diagn. 8(2), 193-201 (2006). (Pubitemid 43811242)
22. Azzoni C, Bottarelli L, Campanini N et al. Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. Int. J. Colorectal Dis. 22(2), 115-126 (2007). (Pubitemid 44964014)
23. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am. J. Gastroenterol. 103(6), 1541-1549 (2008). (Pubitemid 351813919)
24. Mandel JS, Church TR, Bond JH et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N. Engl. J. Med. 343(22), 1603-1607 (2000). (Pubitemid 32162983)
25. Atkin WS, Edwards R, Kralj-Hans I et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 375(9726), 1624-1633 (2010).
26. Hoff G, Grotmol T, Skovlund E, Bretthauer M. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ 338, b1846 (2009).
27. Gohagan JK, Prorok PC, Hayes RB, Kramer BS. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin. Trials 21(6 Suppl.), 251S-272S (2000).
28. Hixson LJ, Fennerty MB, Sampliner RE, McGee D, Garewal H. Prospective study of the frequency and size distribution of polyps missed by colonoscopy. J. Natl Cancer Inst. 82(22), 1769-1772 (1990).
29. Rex DK, Cutler CS, Lemmel GT et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 112(1), 24-28 (1997). (Pubitemid 27008981)
30. Pickhardt PJ, Choi JR, Hwang I et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N. Engl. J. Med. 349(23), 2191-2200 (2003). (Pubitemid 37485135)
31. Pickhardt PJ, Nugent PA, Mysliwiec PA, Choi JR, Schindler WR. Location of adenomas missed by optical colonoscopy. Ann. Intern. Med. 141(5), 352-359 (2004).
32. Rex DK, Petrini JL, Baron TH et al. Quality indicators for colonoscopy. Am. J. Gastroenterol. 101(4), 873-885 (2006).
33. Barclay RL, Vicari JJ, Doughty AS, Johanson JF, Greenlaw RL. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N. Engl. J. Med. 355(24), 2533-2541 (2006). (Pubitemid 44917501)
34. Barclay RL, Vicari JJ, Greenlaw RL. Effect of a time-dependent colonoscopic withdrawal protocol on adenoma detection during screening colonoscopy. Clin. Gastroenterol. Hepatol. 6(10), 1091-1098 (2008).
35. Kaminski MF, Regula J. Colorectal cancer screening by colonoscopy - current issues. Digestion 76(1), 20-25 (2007). (Pubitemid 47608856)
36. Rex DK, Imperiale TF, Latinovich DR, Bratcher LL. Impact of bowel preparation on efficiency and cost of colonoscopy. Am. J. Gastroenterol. 97(7), 1696-1700 (2002). (Pubitemid 34761391)
37. Kaminski MF, Regula J, Kraszewska E et al. Quality indicators for colonoscopy and the risk of interval cancer. N. Engl. J. Med. 362(19), 1795-1803 (2010).
38. Baxter NN, Sutradhar R, Forbes SS et al. Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology 140(1), 65-72 (2010).
39. Lieberman D, Nadel M, Smith RA et al. Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest. Endosc. 65(6), 757-766 (2007). (Pubitemid 46629071)
40. Levin TR, Zhao W, Conell C et al. Complications of colonoscopy in an integrated health care delivery system. Ann. Intern. Med. 145(12), 880-886 (2006). (Pubitemid 351639963)
41. Ko CW, Riffle S, Michaels L et al. Serious complications within 30 days of screening and surveillance colonoscopy are uncommon. Clin. Gastroenterol. Hepatol. 8(2), 166-173 (2010).
42. Nelson DB, McQuaid KR, Bond JH et al. Procedural success and complications of large-scale screening colonoscopy. Gastrointest. Endosc. 55(3), 307-314 (2002). (Pubitemid 41115140)
43. Rabeneck L, Paszat LF, Hilsden RJ et al. Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. Gastroenterology 135(6), 1899-1906, 1906.e1 (2008).
44. Warren JL, Klabunde CN, Mariotto AB et al. Adverse events after outpatient colonoscopy in the Medicare population. Ann. Intern. Med. 150(12), 849-857, W152 (2009).
45. Seeff LC, Richards TB, Shapiro JA et al. How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity. Gastroenterology 127(6), 1670-1677 (2004). (Pubitemid 39575845)
46. Seeff LC, Manninen DL, Dong FB et al. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States? Gastroenterology 127(6), 1661-1669 (2004). (Pubitemid 39575844)
47. Yabroff KR, Klabunde CN, Yuan G et al. Are physicians' recommendations for colorectal cancer screening guideline-consistent? J. Gen. Intern. Med. 26(2), 177-184 (2010).
48. Mysliwiec PA, Brown ML, Klabunde CN, Ransohoff DF. Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann. Intern. Med. 141(4), 264-271 (2004).
49. Walter LC, Lindquist K, Nugent S et al. Impact of age and comorbidity on colorectal cancer screening among older veterans. Ann. Intern. Med. 150(7), 465-473 (2009).
50. Wilkins T, LeClair B, Smolkin M et al. Screening colonoscopies by primary care physicians: a meta-analysis. Ann. Fam. Med. 7(1), 56-62 (2009).
51. Koornstra JJ, Corporaal S, Giezen-Beintema WM, de Vries SE, van Dullemen HM. Colonoscopy training for nurse endoscopists: a feasibility study. Gastrointest. Endosc. 69(3 Pt 2), 688-695 (2009).
52. Klabunde CN, Frame PS, Meadow A et al. A national survey of primary care physicians' colorectal cancer screening recommendations and practices. Prev. Med. 36(3), 352-362 (2003). (Pubitemid 36299087)
53. Maule WF. Screening for colorectal cancer by nurse endoscopists. N. Engl. J. Med. 330(3), 183-187 (1994). (Pubitemid 24026888)
54. Maslekar S, Hughes M, Gardiner A, Monson JR, Duthie GS. Patient satisfaction with lower gastrointestinal endoscopy: doctors, nurse and nonmedical endoscopists. Colorectal Dis. 12(10), 1033-1038 (2010).
55. Morcom J, Dunn SV, Luxford Y. Establishing an Australian nurse practitioner-led colorectal cancer screening clinic. Gastroenterol Nurs. 28(1), 33-42 (2005).
56. Shapero TF, Hoover J, Paszat LF et al. Colorectal cancer screening with nurse-performed flexible sigmoidoscopy: results from a Canadian community-based program. Gastrointest. Endosc. 65(4), 640-645 (2007). (Pubitemid 46454274)
57. Redwood D, Joseph DA, Christensen C et al. Development of a flexible sigmoidoscopy training program for rural nurse practitioners and physician assistants to increase colorectal cancer screening among Alaska Native people. J. Health Care Poor Underserved 20(4), 1041-1048 (2009).
58. Gardiner AB. Results of the United Kingdoms first pilot study for nonmedical endoscopy practitioners. Colorectal Dis. 11(2), 208-214 (2009).
59. Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann. Intern. Med. 133(8), 573-584 (2000).
60. Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann. Intern. Med. 137(2), 96-104 (2002). (Pubitemid 34779153)
61. O'Leary BA, Olynyk JK, Neville AM, Platell CF. Cost-effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy. J. Gastroenterol. Hepatol. 19(1), 38-47 (2004). (Pubitemid 38130605)
62. Zauber AG. Cost-effectiveness of colonoscopy. Gastrointest. Endosc. Clin. N. Am. 20(4), 751-770 (2010).
63. Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Habbema JD, Kuipers EJ. Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. J. Natl Cancer Inst. 101(20), 1412-1422 (2009).
64. Fisher JA, Fikry C, Troxel AB. Cutting cost and increasing access to colorectal cancer screening: another approach to following the guidelines. Cancer Epidemiol. Biomarkers Prev. 15(1), 108-113 (2006).
65. Marshall DA, Johnson FR, Phillips KA et al. Measuring patient preferences for colorectal cancer screening using a choice- format survey. Value Health 10(5), 415-430 (2007). (Pubitemid 47481113)
66. Shokar NK, Carlson CA, Weller SC. Informed decision making changes test preferences for colorectal cancer screening in a diverse population. Ann. Fam. Med. 8(2), 141-150 (2010).
67. Hol L, van Leerdam ME, van Ballegooijen M et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 59(1), 62-68 (2010).
68. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J. Clin. 60(5), 277-300 (2010).
69. Irby K, Anderson WF, Henson DE, Devesa SS. Emerging and widening colorectal carcinoma disparities between blacks and whites in the United States (1975-2002).Cancer Epidemiol. Biomarkers Prev. 15(4), 792-797 (2006).
70. Chao A, Gilliland FD, Hunt WC et al. Increasing incidence of colon and rectal cancer among Hispanics and American Indians in New Mexico (United States), 1969-94. Cancer Causes Control 9(2), 137-144 (1998). (Pubitemid 28160968)
71. Shapiro JA, Seeff LC, Thompson TD et al. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol. Biomarkers Prev. 17(7), 1623-1630 (2008).
72. Doubeni CA, Laiyemo AO, Young AC et al. Primary care, economic barriers to health care, and use of colorectal cancer screening tests among Medicare enrollees over time. Ann. Fam. Med. 8(4), 299-307 (2010).
73. Klabunde CN, Schenck AP, Davis WW. Barriers to colorectal cancer screening among Medicare consumers. Am. J. Prev. Med. 30(4), 313-319 (2006). (Pubitemid 43357920)
74. Maxwell AE, Danao LL, Crespi CM et al. Disparities in the receipt of fecal occult blood test versus endoscopy among Filipino American immigrants. Cancer Epidemiol. Biomarkers Prev. 17(8), 1963-1967 (2008).
75. Hawley ST, Volk RJ, Krishnamurthy P et al. Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients. Med Care. 46(9 Suppl. 1), S10-S16 (2008).
76. Coronado GD, Farias A, Thompson B, Godina R, Oderkirk W. Attitudes and beliefs about colorectal cancer among Mexican Americans in communities along the US-Mexico border. Ethn. Dis. 16(2), 421-427 (2006). (Pubitemid 46952641)
77. Goldman RE, Diaz JA, Kim I. Perspectives of colorectal cancer risk and screening among Dominicans and Puerto Ricans: stigma and misperceptions. Qual. Health Res. 19(11), 1559-1568 (2009).
78. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J. Natl Cancer Inst. 91(5), 434-437 (1999). (Pubitemid 29128279)
79. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348(9040), 1467-1471 (1996). (Pubitemid 26400241)
80. Hardcastle JD, Chamberlain JO, Robinson MH et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348(9040), 1472-1477 (1996). (Pubitemid 26400242)